ArticleCureus2026
Clinical Outcomes and Predictors of Mortality in Variceal Upper Gastrointestinal Bleeding: A Retrospective Study From a Tertiary Care Hospital.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Variceal upper gastrointestinal bleeding (UGIB) is a life-threatening complication of portal hypertension and cirrhosis, associated with high morbidity and mortality. The objective of this study was to evaluate the clinical outcomes and identify independent predictors of six-week mortality in patients presenting with variceal UGIB at a tertiary care center, while providing locally representative data from a large cohort in a low- to middle-income country to strengthen region-specific evidence. Methodology This retrospective observational study was conducted at Shalamar Hospital, Lahore, Pakistan, from June 2020 to June 2025. It included 355 patients admitted with endoscopically confirmed variceal UGIB. Data regarding demographics, clinical presentation, laboratory parameters, endoscopic findings, treatment modalities, and outcomes were collected from hospital records. Results The mean age of patients was 52.3 ± 12.8 years, with 59.7% male patients. Most patients (83.9%) had known cirrhosis, and hematemesis was the most frequent presentation (69.0%). Endoscopic variceal ligation was the commonest intervention (76.3%). Initial hemostasis was achieved in 86.5% of patients. Rebleeding occurred in 20.8%, while the mean hospital stay was 6.9 ± 3.4 days. The overall six-week mortality was 21.1%. Independent predictors of mortality included rebleeding (AOR: 3.91; 95% CI: 2.10-7.30; p < 0.001), Child-Pugh class C (AOR: 2.84; 95% CI: 1.52-5.30; p = 0.001), and hemodynamic instability at admission (AOR: 2.76; 95% CI: 1.44-5.28; p = 0.002). Conclusion Variceal UGIB continues to pose a major clinical challenge, with significant mortality despite effective endoscopic and pharmacological interventions. Advanced liver dysfunction, rebleeding, and shock at presentation strongly predict poor outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.